| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/07/2009 | CA2458684C Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
| 04/07/2009 | CA2450858C Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-.alpha.,.alpha.-dimethylbenzene acetic acid and its hydrochloride |
| 04/07/2009 | CA2420058C Cyclic peptides having melanocortin-4 receptor agonist activity |
| 04/07/2009 | CA2415890C N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 04/07/2009 | CA2413190C Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 04/07/2009 | CA2400554C Pyrimidine-4-one derivatives as ldl-pla2 inhibitors |
| 04/07/2009 | CA2390116C Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 04/07/2009 | CA2372384C Anti-inflammatory bioactive glass particulates |
| 04/07/2009 | CA2361998C Aromatic heterocyclic compounds as anti-inflammatory agents |
| 04/07/2009 | CA2352505C Epothilone derivatives and their use as antitumor agents |
| 04/07/2009 | CA2352503C Il-5 inhibiting 6-azauracil derivatives |
| 04/07/2009 | CA2341991C Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
| 04/07/2009 | CA2341968C Pyrrolobenzodiazepine compounds |
| 04/07/2009 | CA2339253C Inhibitors of p38 |
| 04/07/2009 | CA2320072C Erythropoietin liposomal dispersion |
| 04/07/2009 | CA2267947C Preparation of 3-fluoro oxindole derivatives |
| 04/07/2009 | CA2256633C Selected derivatives of k-252a |
| 04/07/2009 | CA2217737C Thf-containing sulfonamide inhibitors of aspartyl protease |
| 04/07/2009 | CA2151883C Synthetic tropoelastin |
| 04/02/2009 | WO2009042798A1 Methods for treating fibrosis by modulating cellular senescence |
| 04/02/2009 | WO2009041700A1 Pharmaceutical composition |
| 04/02/2009 | WO2009041643A1 Method of modifying isoelectric point of antibody via amino acid substitution in cdr |
| 04/02/2009 | WO2009041570A1 Polymer conjugate of steroid |
| 04/02/2009 | WO2009041567A1 Diaryl ketimine derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 04/02/2009 | WO2009041559A1 Indazole acrylic acid amide compound |
| 04/02/2009 | WO2009041521A1 Quinolone derivative |
| 04/02/2009 | WO2009041456A1 Imidazopyridazine derivative |
| 04/02/2009 | WO2009041453A1 Bicyclic γ-amino acid derivative |
| 04/02/2009 | WO2009041449A1 Antiobesity agent |
| 04/02/2009 | WO2009041447A1 5-membered heterocyclic compound |
| 04/02/2009 | WO2009041072A1 Prophylactic and/or therapeutic agent for anemia, comprising tetrahydroquinoline compound as active ingredient |
| 04/02/2009 | WO2009041037A1 Drug for suppressing pathogen occurring in vivo |
| 04/02/2009 | WO2009041026A1 Cxcl10 production inhibitor |
| 04/02/2009 | WO2009040405A1 Compound and use thereof in the treatment of amyloidosis |
| 04/02/2009 | WO2008005451A3 Optical apparatus and methods for chemical analysis |
| 04/02/2009 | US20090088484 Nitric oxide (no)-releasing polymers and compounds and uses thereof |
| 04/02/2009 | US20090087905 VEGF-D polynucleotides and methods of use |
| 04/02/2009 | US20090087501 Oral Compositions Containing Botanical Extracts |
| 04/02/2009 | US20090087498 Shampoo formulation for treatment of hair loss and method of use |
| 04/02/2009 | US20090087497 Compositions and methods for treating symptoms of aging |
| 04/02/2009 | US20090087423 Novel protein complex and use thereof |
| 04/02/2009 | US20090087420 Stable solution of reduced coenzyme q |
| 04/02/2009 | US20090087410 Treatment of hypersensitivity |
| 04/02/2009 | US20090087409 Viral Polymerase Inhibitors |
| 04/02/2009 | US20090087380 Polymer devices for therapeutic applications |
| 04/02/2009 | CA2700701A1 Method of modifying isoelectric point of antibody via amino acid substitution in cdr |
| 04/02/2009 | CA2700596A1 Compound and use thereof in the treatment of amyloidosis |
| 04/02/2009 | CA2700113A1 Indazole acrylic acid amide compound |
| 04/02/2009 | CA2700088A1 Quinolone derivative |
| 04/01/2009 | EP2042596A1 Polypeptides involved in immune response |
| 04/01/2009 | EP2042510A2 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleid acid (siNA) |
| 04/01/2009 | EP2042503A1 Compound having acidic group which may be protected, and use thereof |
| 04/01/2009 | EP2042502A1 Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor |
| 04/01/2009 | EP2042498A1 Crystal of benzoxadiazole derivative |
| 04/01/2009 | EP2042480A1 Aminoindan derivative or salt thereof |
| 04/01/2009 | EP2042196A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF) |
| 04/01/2009 | EP2042194A2 Treatment of refractory human tumors with epidermal growth factor receptor antagonists |
| 04/01/2009 | EP2042173A2 Kappa-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
| 04/01/2009 | EP2042170A1 Creatine composition and use |
| 04/01/2009 | EP2042168A1 Inhalation device comprising phenethanolamine derivatives for treatment of respiratory diseases |
| 04/01/2009 | EP2042163A1 Pharmaceutical compositions comprising fluvastatin |
| 04/01/2009 | EP2041068A1 Positively charged water-soluble prodrugs of ibuprofen with very fast skin penetration rate |
| 04/01/2009 | EP2040754A1 Use of adipose-tissue cell fractions for post-irradiation tissue regeneration |
| 04/01/2009 | EP2040734A2 Antisecretory protein for use in the treatment of compartment syndrome |
| 04/01/2009 | EP2040706A2 Modulators of muscarinic receptors |
| 04/01/2009 | EP1549341B1 Tissue factor targeted antibodies as anticoagulants |
| 04/01/2009 | EP1473295B1 Fused bicyclic pyrimidine derivatives |
| 04/01/2009 | EP1427825B1 Cdna encoding the human alpha2 delta4 calcium channel subunit |
| 04/01/2009 | EP1349873B1 Modulation of il-2- and il-15-mediated t cell responses |
| 04/01/2009 | EP1082308B1 Heterocyclically substituted amides used as calpain inhibitors |
| 04/01/2009 | EP0970207B1 Heregulin variants |
| 04/01/2009 | CN101400670A Novel pyridine derivative having anti-helicobacter pylori activity |
| 04/01/2009 | CN101400659A Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 04/01/2009 | CN101400657A Polycyclic cinnamide derivative |
| 04/01/2009 | CN101400347A Combination of alpha-2 receptor agonist (clonidin) and an anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea |
| 04/01/2009 | CN101400333A Skin-whitening agent for external application to the skin, and method for whitening the skin |
| 04/01/2009 | CN101397564A Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 04/01/2009 | CN101397295A 2-dihydroindolemanone derivates as histone deacetylase inhibitor, preparation method and use thereof |
| 04/01/2009 | CN101396520A Preparation method of spleen-invigorating and kidney-strengthening traditional Chinese medicine |
| 04/01/2009 | CN101396457A Traditional Chinese medicine composition for treating stomach intestine adynamia of multi viscera organs incompetence syndrome |
| 04/01/2009 | CN101396447A Method for increasing the predation performance of spider using agrimony extract |
| 04/01/2009 | CN101396446A Method for increasing the parasitism performance of parasitic wasp |
| 04/01/2009 | CN101396384A Asiatic centella extract and preparation methode thereof |
| 04/01/2009 | CN101396352A Compositions and methods for treating amyloidosis |
| 04/01/2009 | CN101396055A Pseudo-ginseng pu'er tea |
| 04/01/2009 | CN100473721C Pneumovirus NS proteins antagonising interferon (IFN) response |
| 04/01/2009 | CN100473662C Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 04/01/2009 | CN100473648C 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors |
| 04/01/2009 | CN100473376C Stabilized aqueous suspensions for parenteral administration |
| 04/01/2009 | CN100473291C Food or pet food composition containing plant extract for bone health |
| 03/31/2009 | US7511159 Azetidine ring compounds and drugs comprising the same |
| 03/31/2009 | US7511144 Reverse hydroxamic acid derivatives |
| 03/31/2009 | US7511138 Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles |
| 03/31/2009 | US7511136 Anticancer agents; antiproliferative agents; Alzheimer's disease; viricides; autoimmune diseases; central nervous system disorders |
| 03/31/2009 | US7511121 Polymeric immunoglobulin fusion proteins that target low-affinity Fcγreceptors |
| 03/31/2009 | US7511078 Antiallergic agents, drugs, foods, drinks or cosmetics containing them and process for producing the same |
| 03/31/2009 | US7511075 Therapeutic malonic acid/acetic acid C60 tri-adducts of buckminsterfullerene and methods related thereto |
| 03/31/2009 | US7511074 A 5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, acid ester, sulfonic acid or amide derivatives, for treating Alzheimer's disease, Parkinson's disease and Huntington's disease, epilepsy, stroke |
| 03/31/2009 | US7511073 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/31/2009 | US7511069 Indazole compounds as β3 andrenoceptor agonist |